Lung cancer combo shows promise in trial
NCT ID NCT03133546
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study tested whether adding bevacizumab to osimertinib helps people with advanced non-small cell lung cancer that has a specific genetic change (EGFR and T790M mutations). 155 adults who had already tried other treatments took part. The main goal was to see if the combination slowed cancer growth better than osimertinib alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER METASTATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
-
Fund. Jimenez Diaz
Madrid, Spain
-
Geneva University Hospital (HUG)
Geneva, Switzerland
-
Hospital Arnau de Vilanova
Valencia, Spain
-
Hospital General Alicante
Alicante, Spain
-
Hospital General de Valencia
Valencia, Spain
-
Hospital Puerta de Hierro
Madrid, Spain
-
Hospital Sant Pau
Barcelona, Spain
-
Hospital Teresa Herrara
A Coruña, Spain
-
Hospital Virgen del Rocio
Seville, Spain
-
Hospital de la Princesa
Madrid, Spain
-
Hospital la Paz
Madrid, Spain
-
ICO Badalona
Barcelona, Spain
-
ICO Hospitalet
Barcelona, Spain
-
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
-
Kantonsspital Winterthur
Winterthur, Switzerland
-
Mid Western Cancer Centre
Limerick, Ireland
-
National Cancer Centre
Goyang, South Korea
-
National University Hospital
Singapore, Singapore
-
OSI Bilbao Basurto
Bilbao, Spain
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
-
St. James Hospital
Dublin, Ireland
-
Tan Tock Seng Hospital
Singapore, Singapore
-
UniversitatSpital Zurich
Zurich, Switzerland
-
VU University Medical Centre
Amsterdam, Netherlands
Conditions
Explore the condition pages connected to this study.